|
RREB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.84619999474978E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.73300000017029E-07 |
| Normal-vs-Stage2 |
6.01529999999517E-05 |
| Normal-vs-Stage3 |
2.83129999445464E-08 |
| Normal-vs-Stage4 |
4.61100000404002E-08 |
| Stage1-vs-Stage2 |
3.668800E-01 |
| Stage1-vs-Stage3 |
2.349000E-01 |
| Stage1-vs-Stage4 |
2.364400E-01 |
| Stage2-vs-Stage3 |
1.012000E-01 |
| Stage2-vs-Stage4 |
1.125830E-01 |
| Stage3-vs-Stage4 |
9.139600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.36380000415448E-08 |
| Normal-vs-AfricanAmerican |
1.815960E-02 |
| Normal-vs-Asian |
1.88959999980476E-07 |
| Caucasian-vs-AfricanAmerican |
3.041900E-02 |
| Caucasian-vs-Asian |
7.892000E-01 |
| AfricanAmerican-vs-Asian |
3.746000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.70680000028045E-07 |
| Normal-vs-Female |
7.63140000081819E-08 |
| Male-vs-Female |
6.878000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.85470000024779E-07 |
| Normal-vs-Age(41-60Yrs) |
1.20980000017923E-07 |
| Normal-vs-Age(61-80Yrs) |
3.44509999972153E-07 |
| Normal-vs-Age(81-100Yrs) |
1.258310E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.602800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.762400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.750600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.561800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.235400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.634800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.19760000000391E-05 |
| Classical-VS-Follicular |
9.349800E-01 |
| Classical-VS-Other |
4.008000E-01 |
| Classical-VS-Normal |
6.79959999971835E-07 |
| Tall-VS-Follicular |
2.476600E-03 |
| Tall-VS-Other |
4.307600E-01 |
| Tall-VS-Normal |
3.00560021315732E-10 |
| Follicular-VS-Other |
4.742600E-01 |
| Follicular-VS-Normal |
2.4344000000287E-06 |
| Other-VS-Normal |
2.430100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.53470000041622E-07 |
| Normal-vs-N1 |
2.77539999982146E-07 |
| N0-vs-N1 |
5.394400E-01 |
|
|
